Tag: Daniel Cendan
Firms advise on RemeGen’s USD5.6bn AbbVie licensing deal
Freshfields and Global Law Office have advised Chinese biotech RemeGen on an exclusive licensing agreement with AbbVie
English
Freshfields and Global Law Office have advised Chinese biotech RemeGen on an exclusive licensing agreement with AbbVie
Draft Advocates Amendment Bill 2026 could formalise law firms, mandate registration and admit foreign practices
91视频 senior advocate designation forces partners to leave firms, but reforms may allow continued affiliation
Follow us on LinkedIn